Suche
Kategorie
Erscheinungsjahr
51945 Treffer
×
Publikationen
×
Johannes Gutenberg-Universität Mainz
×
Universität Koblenz
×
Katholische Hochschule Mainz
×
Theologische Fakultät Trier
- Alwers, Elizabeth; Jansen, Lina; Blaeker, Hendrik et al.
- Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population-based study
- MOLECULAR ONCOLOGY. 2020
- Hempler, I.; Riccetti, N.; Hermes-Moll, K. et al.
- Psycho-oncological care of cancer patients with a migration background ("POM Study") - First results of the qualitative interviews
- ONCOLOGY RESEARCH AND TREATMENT. Bd. 43. H. SUPPL 4. 2020 S. 226-226
- Francque, Sven M.; Bedossa, Pierre; Ratziu, Vlad et al.
- THE PANPPAR AGONIST LANIFIBRANOR INDUCES BOTH RESOLUTION OF NASH AND REGRESSION OF FIBROSIS AFTER 24 WEEKS OF TREATMENT IN NON-CIRRHOTIC NASH: RESULTS OF THE NATIVE PHASE 2b TRIAL
- HEPATOLOGY. Bd. 72. 2020 S. 9A-11A
- Triantafyllias, K.; Klonowski, A.; Cavagna, L. et al.
- SYSTEMATIC CORONARY RISK EVALUATION (SCORE) MISCLASSIFIES CARDIOVASCULAR RISK IN ANTISYNTHETASE SYNDROME: RESULTS OF THE PILOT MULTICENTRIC STUDY RI.CARDA
- ANNALS OF THE RHEUMATIC DISEASES. Bd. 79. 2020 S. 411-411
- Finn, R. S.; Qin, S-K.; Galle, P. R. et al.
- Ramucirumab in patients with advanced hepatocellular carcinoma and elevated alpha fetoprotein following a non-sorafenib based systemic therapy: An expansion cohort of the phase III REACH-2 study
- ANNALS OF ONCOLOGY. Bd. 31. 2020 S. S702-S702
- Kudo, Masatoshi; Galle, Peter R.; Llovet, Josep M. et al.
- Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib in REACH and REACH-2
- LIVER INTERNATIONAL. Bd. 40. H. 8. 2020 S. 2008-2020
- Zhu, Andrew X.; Ikeda, Masafumi; Galle, Peter R. et al.
- Ramucirumab in patients with advanced HCC and elevated alpha-fetoprotein (AFP): Outcomes by treatment-emergent ascites.
- JOURNAL OF CLINICAL ONCOLOGY. Bd. 38. H. 15. 2020
- Labenz, Christian; Kostev, Karel; Galle, Peter R. et al.
- Proton pump inhibitor use is associated with a variety of infections in patients with liver cirrhosis
- MEDICINE. Bd. 99. H. 50. 2020
- Anstee, Q. M.; Harrison, S.; Sanyal, Arun J. et al.
- Obeticholic acid (OCA) improves non-invasive markers of fibrosis in patients with non-alcoholic steatohepatitis (NASH): a secondary analysis of the phase 3 Regenerate study
- DIGESTIVE AND LIVER DISEASE. Bd. 52. 2020 S. E41-E42
- Anstee, Q. M.; Harrison, S.; Sanyal, A. J. et al.
- OBETICHOLIC ACID (OCA) IMPROVES NON-INVASIVE MARKERS OF FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH): A SECONDARY ANALYSIS OF THE PHASE 3 REGENERATE STUDY
- DIGESTIVE AND LIVER DISEASE. Bd. 52. 2020 S. S163-S163